LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes

CompletadoClinicalTrials.gov

ID: NCT01318941Tipo: OBSERVATIONALInicio: 1 de mar de 2011Fin estimado: 1 de abr de 2016

Traducción no disponible, mostrando original

Resumen

This study will describe the long-term safety and effectiveness, treatment patterns,and patient reported quality of life associated with ranibizumab treatment in routine clinical practice for all approved indication included in the local product label.

Elegibilidad

Sexo: ALL

Criterios de inclusión

Willing and able to provide informed written consent personally or by legal proxy
Adult patients, within age limits as defined by local regulations and local product label, who have previously been treated with, who are currently being treated with or initiating treatment with ranibizumab for any approved indication included in the local product label

Criterios de exclusión

Simultaneous participation in a study that includes administration of any investigational drug or procedure
Systemic or ocular treatment with any VEGF inhibitor other than ranibizumab in the 90 days prior to enrollment

Intervenciones

drug

Ranibizumab

other

Ranibizumab

Ubicaciones

Novartis Investigative Site

Buenos Aires, Argentina, Argentina

Novartis Investigative Site

Concepción del Uruguay, Argentina, Argentina

Novartis Investigative Site

Córdoba, Argentina, Argentina

Novartis Investigative Site

Guaymallén, Mendoza, Argentina, Argentina

Novartis Investigative Site

Rosario, Argentina, Argentina

Novartis Investigative Site

San Martin, Buenos Aires, Argentina, Argentina

Novartis Investigative Site

Santa Fe, Argentina, Argentina

Novartis Investigative Site

Lanús, Buenos Aires, Argentina

Novartis Investigative Site

Mar del Plata, Buenos Aires, Argentina

Novartis Investigative Site

Rosario, Santa Fe Province, Argentina

Novartis Investigative Site

Buenos Aires, Argentina

Novartis Investigative Site

Buenos Aires, Argentina

Novartis Investigative Site

Buenos Aires, Argentina

Novartis Investigative Site

Caballito, Argentina

Novartis Investigative Site

Ciudad de Buenos Aires,, Argentina

Novartis Investigative Site

La Plata, Argentina

Novartis Investigative Site

Santa Fe, Argentina

Patrocinadores

PrincipalNovartis Pharmaceuticals

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

LUMINOUS: Study to Observe the Effectiveness and Safety o... | EligiMed